Home ⟩ Insights

Insights

opinion

3 min read • January 15, 2024

Reschedule Cannabis Or ‘Abolish The DEA,’ Says Physician: Examining The 50-Year-Old, Trillion-Dollar Agency

4 min read • March 13, 2023

Two Years Later And Retailers Are No Closer To Cannabis Licenses In New York State

2 min read • March 10, 2023

Will CBDCs Kill Bitcoin Like Fed’s Powell Says? Here’s Why They Might Actually Pump It Up Further

5 min read • February 7, 2023

Cannabis In 2023: A Make It Or Break It Year

4 min read • November 12, 2022

Opinion: Why Republicans Should Support Descheduling Marijuana

3 min read • November 4, 2022

What Does The Shake Up In The Cannabis Media Industry Mean For Weed’s Mainstreaming?

5 min read • October 10, 2022

How Cannabis Can Redefine Corporate Wellness

9 min read • September 28, 2022

The Development Cost and Features of Cannabis Delivery Web Application

6 min read • September 17, 2022

Playboy CEO Urges Congress To End Weed Prohibition

8 min read • July 26, 2022

These Are The Top Medical Cannabis Strains

5 min read • June 3, 2022

Laura Ingraham Blames Cannabis, Not Guns, For Mass Shootings: Whoopi Goldberg Responds

4 min read • May 18, 2022

Music And Cannabis Branding Opportunities

Latest Headlines

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

3 min read • August 26, 2026

Financial Times: Germany’s Cannabis Imports Surge Sixfold, Regulatory Pressure Mounts

3 min read • August 25, 2026

Comply With What? Hemp Ban Nears; the FDA Leaves Industry Waiting for Answers

4 min read • August 25, 2026

Curaleaf vs. Aurora: The $4 Cannabis Takeover Fight Gets Hostile — Literally

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.